Planned phase II trial of IT-101 in patients with relapsed or refractory lymphoma.
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2011
At a glance
- Drugs Camptothecin (Primary)
- Indications B cell lymphoma; Hodgkin's disease; T cell lymphoma
- Focus Adverse reactions
- 18 Jun 2008 New trial record.